PRKN and Parkinson disease: It was found that Miro, a substrate of Parkin, was resistant to proteasomal degradation induced by mitochondrial depolarization, interferencing mitochondrial mobility and initiation of mitophagy in PD patients with LRRK2 G2019S mutation and sporadic PD patients7.